Sixteen Years of Overregulation: Time to Unburden Mifeprex.

Raymond, Elizabeth G; Blanchard, Kelly; Blumenthal, Paul D; Cleland, Kelly; Foster, Angel M; Gold, Marji; Grossman, Daniel; Pendergast, Mary K; Westhoff, Carolyn L; Winikoff, Beverly

Raymond, Elizabeth G; Blanchard, Kelly; Blumenthal, Paul D; Cleland, Kelly; Foster, Angel M; Gold, Marji; Grossman, Daniel; Pendergast, Mary K; Westhoff, Carolyn L; Winikoff, Beverly.

Afiliação

Raymond EG; Gynuity Health Projects, New York, NY
Blanchard K; Ibis Reproductive Health, Cambridge, MA
Blumenthal PD; Division of Family Planning Services and Research, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA
Cleland K; Office of Population Research, Princeton University, Princeton, NJ
Foster AM; Faculty of Health Sciences, University of Ottawa, Ottawa
Gold M; Albert Einstein College of Medicine, Bronx, NY
Grossman D; Advancing New Standards in Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA
Pendergast MK; Pendergast Consulting, Washington DC
Westhoff CL; Columbia University, New York, NY
Winikoff B; Gynuity Health Projects, New York, NY

N Engl J Med ; 376(8): 790-794, 2017 02 23.

Article em En | MEDLINE | ID: mdl-28225670

Assuntos

Abortivos Esteroides; Rotulagem de Medicamentos/legislação & jurisprudência; Regulamentação Governamental; Mifepristona; Humanos; Legislação de Medicamentos; Estados Unidos; United States Food and Drug Administration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Abortivos Esteroides / Mifepristona / Regulamentação Governamental / Rotulagem de Medicamentos Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: N Engl J Med Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google